Fatty Liver & Cardiology

​​FRIDAY JUNE 2​

Session 4: NASH and Cardiovascular Disease - Panel Discussion
08:00-10:00
Hall A

NAFLD and Cardiovascular Disease- Weighing the Evidence Critically 
Khurram Nasir (USA)
Atherogenic Dyslipidemia and NAFLD
Arun J. Sanyal (USA)
Cardiomyopathy Associated with NAFLD
Mohammed Siddiqui (USA)
Coagulation and NAFLD
J.A.(Ton) Lisman (Netherlands) 


SATURDAY JUNE 3​

Session 11: Therapeutic Landscape for NASH - Panel Discussion
16:00-18:00
Hall A

Chair: Manuel Romero Gomez (Spain)

Current Compounds in Pivotal Trials
Vlad Ratziu (France)
Targets Under Evaluation in Early Phase Trials
Quentin M. Anstee (UK)
Drugs You Can Use in Your Office Today
Arun Sanyal (USA)
Bariatric Surgery-What is its Role
Rifaat Safadi (Israel) 

yellow_preliminary-scientific-program.jpg ​


Keep Me Updated


​​​ ​​​​​ ​​​​​ ​​​​​